Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Pieris Pharmaceuticals, Inc.
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Pieris Pharmaceuticals, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Pieris Pharmaceuticals, Inc. since 2005.
The reporting company's ticker symbol is PIRS. The reporting company's CIK number is 1583648.
The total value of stock buying since 2005 is $3,146,966.
The total value of stock sales since 2005 is $13,478,141.
The total value of stock option exercises since 2005 is $389,147.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2018-02-13||Orbimed Capital Gp Iii Llc||Sale||7,897||8.98||70,915|
|2018-02-13||Orbimed Capital Gp Iii Llc||Option Ex||7,897||4.88||38,537|
|2018-01-03||Isaly Samuel D||Sale||1,709,620||7.35||12,565,707|
|2017-12-18||Isaly Samuel D||Sale||147,635||5.70||841,519|
|2017-12-18||Isaly Samuel D||Option Ex||147,635||2.32||342,660|
|2017-08-17||Reine Allan (See Remarks)||Buy||20,000||4.89||97,800|
|2017-08-17||Geraghty James A (Director)||Buy||10,000||4.82||48,200|
|2017-08-16||Reine Allan (See Remarks)||Buy||45,000||4.79||215,550|
|2017-04-21||Kiritsy Christopher P (Director)||Option Ex||5,000||1.59||7,950|
|2016-06-14||Matis Louis (SVP, Chief Development Officer)||Buy||7,915||1.71||13,534|
|2016-06-13||Matis Louis (SVP, Chief Development Officer)||Buy||2,085||1.68||3,502|
|2016-06-13||Yoder Stephen S. (President and CEO)||Buy||6,000||1.68||10,080|
|2016-06-13||Deptula-hicks Darlene M (SVP, Chief Financial Officer)||Buy||5,000||1.66||8,300|
|2015-07-06||Khuong Chau Quang (Director)||Buy||500,000||2.75||1,375,000|
|2015-07-06||Isaly Samuel D (Director)||Buy||500,000||2.75||1,375,000|
Insider trading activities including stock purchases, stock sales, and option exercises of PIRS listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Pieris Pharmaceuticals, Inc. (symbol PIRS, CIK number 1583648) see the Securities and Exchange Commission (SEC) website.